BIOMAT Database Logo BIOMAT Database Logo

[Differential pathogenetic therapy in the complex treatment of patients with destructive pulmonary tuberculosis]. 1982

V N Molotkov, and O M Ivaniuta, and V I Bystritskaia, and V N Mel'nik

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D014397 Tuberculosis, Pulmonary MYCOBACTERIUM infections of the lung. Pulmonary Consumption,Pulmonary Phthisis,Pulmonary Tuberculoses,Pulmonary Tuberculosis,Tuberculoses, Pulmonary,Consumption, Pulmonary,Consumptions, Pulmonary,Phthises, Pulmonary,Phthisis, Pulmonary,Pulmonary Consumptions,Pulmonary Phthises

Related Publications

V N Molotkov, and O M Ivaniuta, and V I Bystritskaia, and V N Mel'nik
[Pathogenetic therapy of destructive pulmonary tuberculosis].
January 1976, Problemy tuberkuleza,
V N Molotkov, and O M Ivaniuta, and V I Bystritskaia, and V N Mel'nik
[Insulin therapy in the complex treatment of destructive pulmonary tuberculosis].
November 1980, Problemy tuberkuleza,
V N Molotkov, and O M Ivaniuta, and V I Bystritskaia, and V N Mel'nik
[Complex treatment of destructive pulmonary tuberculosis].
January 2003, Problemy tuberkuleza i boleznei legkikh,
V N Molotkov, and O M Ivaniuta, and V I Bystritskaia, and V N Mel'nik
[Surgical stage in the complex therapy of patients with extensive destructive pulmonary tuberculosis].
January 1970, Problemy tuberkuleza,
V N Molotkov, and O M Ivaniuta, and V I Bystritskaia, and V N Mel'nik
[Pulmonary scintigraphy in evaluating the efficiency of surfactant therapy in the complex treatment of patients with destructive pulmonary tuberculosis].
January 2006, Vestnik rentgenologii i radiologii,
V N Molotkov, and O M Ivaniuta, and V I Bystritskaia, and V N Mel'nik
[Pathogenetic mechanisms of impaired intestinal microflora in patients with destructive pulmonary tuberculosis].
January 2001, Problemy tuberkuleza,
V N Molotkov, and O M Ivaniuta, and V I Bystritskaia, and V N Mel'nik
[Use of myelopid in the complex treatment of patients with destructive pulmonary tuberculosis].
January 1990, Problemy tuberkuleza,
V N Molotkov, and O M Ivaniuta, and V I Bystritskaia, and V N Mel'nik
[Use of indomethacin in the complex treatment of patients with destructive pulmonary tuberculosis].
January 1985, Problemy tuberkuleza,
V N Molotkov, and O M Ivaniuta, and V I Bystritskaia, and V N Mel'nik
[NK cells in patients during complex therapy of destructive pulmonary tuberculosis].
January 1989, Problemy tuberkuleza,
V N Molotkov, and O M Ivaniuta, and V I Bystritskaia, and V N Mel'nik
[Methyluracil in the complex treatment of destructive pulmonary tuberculosis].
November 1980, Problemy tuberkuleza,
Copied contents to your clipboard!